Compounds > framycetin
Page last updated: 2024-08-18

framycetin and triiodothyronine

framycetin has been researched along with triiodothyronine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Beug, H; Bugge, T; Disela, C; Dodgson, J; Glineur, C; Sap, J; Stengl, G; Stunnenberg, H; Zenke, M1
Ametov, AS; Shuvalova, IE; Skvortsova, RI1

Other Studies

5 other study(ies) available for framycetin and triiodothyronine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
    Bioorganic & medicinal chemistry, 2010, Nov-01, Volume: 18, Issue:21

    Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII.
    Genes & development, 1991, Volume: 5, Issue:11

    Topics: Base Sequence; Binding Sites; Blotting, Northern; Carbonic Anhydrases; Cell Differentiation; Cell Line, Transformed; Drug Resistance; Erythroblasts; Gene Expression Regulation; Genes, gag; HeLa Cells; Humans; Luciferases; Molecular Sequence Data; Neomycin; Oncogene Proteins v-erbA; Plasmids; Precipitin Tests; Proto-Oncogene Proteins; Receptors, Thyroid Hormone; Retroviridae Proteins, Oncogenic; Triiodothyronine; Vaccinia virus

1991
[Effect of neomycin on certain indicators of carbohydrate and cortisol metabolism and level of thyroid hormones in toxic goiter].
    Vrachebnoe delo, 1974, Volume: 0, Issue:8

    Topics: 17-Hydroxycorticosteroids; Adult; Carbohydrate Metabolism; Citrates; Female; Graves Disease; Humans; Hydrocortisone; Lactates; Male; Middle Aged; Neomycin; Pyruvates; Thyroxine; Triiodothyronine

1974